2,955
Views
8
CrossRef citations to date
0
Altmetric
Research Article

Antidepressant effects of total iridoids of Valeriana jatamansi via the intestinal flora-blood–brain barrier pathway

, , , , , , , , , , , , , , , , , & show all
Pages 910-919 | Received 24 Feb 2021, Accepted 13 Jun 2021, Published online: 08 Jul 2021

References

  • Biala G, Pekala K, Boguszewska-Czubara A, Michalak A, Kruk-Slomka M, Budzynska B. 2017. Behavioral and biochemical interaction between nicotine and chronic unpredictable mild stress in mice. Mol Neurobiol. 54(2):904–921.
  • Braniste V, Al-Asmakh M, Kowal C, Anuar F, Abbaspour A, Tóth M, Korecka A, Bakocevic N, Kundu P, Gulyás B, et al. 2014. The gut microbiota influences blood-brain barrier permeability in mice. Sci Transl Med. 6(263):263ra158.
  • Cipriani A, Furukawa TA, Salanti G, Chaimani A, Atkinson LZ, Ogawa Y, Leucht S, Ruhe HG, Turner EH, Higgins JPT, et al. 2018. Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis. The Lancet. 391(10128):1357–1366.
  • Cryan J, Dinan T. 2015. Gut microbiota: microbiota and neuroimmune signalling-Metchnikoff to microglia. Nat Rev Gastroenterol Hepatol. 12(9):494–496.
  • Deng L, Chen H, Wei N, Zhang Z, Wang G. 2019. The cardioprotective effect of dexmedetomidine on regional ischemia/reperfusion injury in type 2 diabetic rat hearts. Microvasc Res. 123:1–6.
  • Di Marco A, Vignone D, Gonzalez Paz O, Fini I, Battista MR, Cellucci A, Bracacel E, Auciello G, Veneziano M, Khetarpal V, et al. 2020. Establishment of an in vitro human blood–brain barrier model derived from induced pluripotent stem cells and comparison to a porcine cell-based system. Cells. 9(4):994–922.
  • Dong FW, Jiang HH, Yang L, Gong Y, Zi CT, Yang D, Ye CJ, Li H, Yang J, Nian Y, et al. 2018. Valepotriates from the roots and rhizomes of Valeriana jatamansi Jones as novel N-type calcium channel antagonists. Front Pharmacol. 9:1–9.
  • Feng S, Zou L, Wang H, He R, Liu K, Zhu H. 2018. RhoA/ROCK-2 pathway inhibition and tight junction protein upregulation by catalpol suppresses lipopolysaccaride-induced disruption of blood–brain barrier permeability. Molecules. 23(9):2371– 2317.
  • Gao YB, Xiang LI, Wang SM, Zhao L, Yao BW. 2011. Application of Evans blue dye to the detection of permeability of BBB after microwave radiation. Milit Med Sci. 35:391–393.
  • Gartlehner G, Morgan LC, Richard HA. 2012. P-1102 - Comparative effectiveness of second-generation antidepressants in the pharmacologic treatment of adult depression. Eur Psychiat. 27:1–1.
  • Huang J, Zhang W, Fan R, Liu Z, Huang T, Li J, Du T, Xiong T. 2020. Composition and functional diversity of fecal bacterial community of wild boar, commercial pig and domestic native pig as revealed by 16S rRNA gene sequencing. Arch Microbiol. 202(4):843–857.
  • Jing Y, Yang DX, Wang W, Yuan F, Chen H, Ding J, Geng Z, Tian HL. 2020. Aloin protects against blood-brain barrier damage after traumatic brain injury in mice. Neurosci Bull. 36(6):625–638.
  • Kealy J, Greene C, Campbell M. 2020. Blood-brain barrier regulation in psychiatric disorders. Neurosci Lett. 726:133664.
  • Khan A-u, Gilani A-H. 2011. Pharmacological basis for the medicinal use of Valeriana wallichii in constipation. Lat Am J Pharm. 30(1):186–188.
  • Kigerl KA, Hall JC, Wang L, Mo X, Yu Z, Popovich PG. 2016. Gut dysbiosis impairs recovery after spinal cord injury. J Exp Med. 213(12):2603–2620.
  • Lach G, Schellekens H, Dinan TG, Cryan JF. 2018. Anxiety, depression, and the microbiome: a role for gut peptides. Neurotherapeutics. 15(1):36–59.
  • Letchamo W, Ward W, Heard B, Heard D. 2004. Essential oil of Valeriana officinalis L. cultivars and their antimicrobial activity as influenced by harvesting time under commercial organic cultivation. J Agric Food Chem. 52(12):3915–3919.
  • Li J, Peng L, Huang HH, Cao H. 2009. Research progress of in vitro model building of blood–brain barrier. Acad J Guangdong Coll Pharm. 30:647–648.
  • Li R. 2009. Extraction and analysis of flavonoids from Valeriana jatamansi and its anti-inflammatory and antibacterial activities [master’s thesis]. Jiangsu: Suzhou University.
  • Li SZ. 1975. Compendium of materia mdica. Beijing: People's Medical Publishing House.
  • Li Y, Wu L, Chen C, Wang L, Guo C, Zhao X, Zhao T, Wang X, Liu A, Yan Z. 2020. Serum metabolic profiling reveals the antidepressive effects of the total iridoids of Valeriana jatamansi Jones on chronic unpredictable mild stress mice. Front Pharmacol. 11:1–13.
  • Lin S, Shen Y-H, Li H-L, Yang X-W, Chen T, Lu L-H, Huang Z-S, Liu R-H, Xu X-K, Zhang W-D, et al. 2009. Acylated iridoids with cytotoxicity from Valeriana jatamansi. J Nat Prod. 72(4):650–655.
  • Nadeem I, Rahman MZ, Ad-Dab'bagh Y, Akhtar M. 2019. Effect of probiotic interventions on depressive symptoms: a narrative review evaluating systematic reviews. Psychiatry Clin Neurosci. 73(4):154–162.
  • Nakagawasai O, Yamada K, Takahashi K, Odaira T, Sakuma W, Ishizawa D, Takahashi N, Onuma K, Hozumi C, Nemoto W, et al. 2020. Liver hydrolysate prevents depressive-like behavior in an animal model of colitis: involvement of hippocampal neurogenesis via the AMPK/BDNF pathway. Behav Brain Res. 390:112640.
  • Nighot PK, Leung L, Ma TY. 2017. Chloride channel ClC- 2 enhances intestinal epithelial tight junction barrier function via regulation of caveolin-1 and caveolar trafficking of occludin. Exp Cell Res. 352(1):113–122.
  • Ochoa-Reparaz J, Kasper LH. 2016. The second brain: is the gut microbiota a link between obesity and central nervous system disorders? Curr Obes Rep. 5(1):51–64.
  • Pascale A, Marchesi N, Govoni S, Barbieri A. 2020. Targeting the microbiota in pharmacology of psychiatric disorders. Pharmacol Res. 157:104856.
  • Pascale A, Marchesi N, Marelli C, Coppola A, Luzi L, Govoni S, Giustina A, Gazzaruso C. 2018. Microbiota and metabolic diseases. Endocrine. 61(3):357–371.
  • Perrech M, Dreher L, Rohn G, Stavrinou P, Krischek B, Toliat M, Goldbrunner R, Timmer M. 2019. Qualitative and quantitative analysis of IDH1 mutation in progressive gliomas by allele-specific qPCR and Western Blot Analysis. Technol Cancer Res Treat. 18:1533033819828396.
  • Ploger S, Stumpff F, Penner GB, Schulzke JD, Gabel G, Martens H, Shen Z, Gunzel D, Aschenbach JR. 2012. Microbial butyrate and its role for barrier function in the gastrointestinal tract. Ann N Y Acad Sci. 1258:52–59.
  • Prasad R, Naime M, Routray I, Mahmood A, Khan F, Ali S. 2010. Valeriana jatamansi partially reverses liver cirrhosis and tissue hyperproliferative response in rat. Methods Find Exp Clin Pharmacol. 32(10):713–719.
  • Qin J, Li R, Raes J, Arumugam M, Burgdorf KS, Manichanh C, Nielsen T, Pons N, Levenez F, Yamada T, Mende DR.; MetaHIT Consortium. 2010. A human gut microbial gene catalogue established by metagenomic sequencing. Nature. 464(7285):59–65.
  • Riaz Rajoka MS, Shi J, Mehwish HM, Zhu J, Li Q, Shao D, Huang Q, Yang H. 2017. Interaction between diet composition and gut microbiota and its impact on gastrointestinal tract health. Food Sci Human Wellness. 6(3):121–130.
  • Rieder R, Wisniewski PJ, Alderman BL, Campbell SC. 2017. Microbes and mental health: a review. Brain Behav Immun. 66:9–17.
  • Rook GA, Lowry CA, Raison CL. 2013. Microbial ‘Old Friends’, immunoregulation and stress resilience. Evol Med Public Health. 2013(1):46–64.
  • Sah SP, Mathela CS, Chopra K. 2010. Elucidation of possible mechanism of analgesic action of Valeriana wallichii DC chemotype (patchouli alcohol) in experimental animal models. Indian J Exp Biol. 48(3):289–293.
  • Sherwin E, Sandhu KV, Dinan TG, Cryan JF. 2016. May the force be with you: the light and dark sides of the Microbiota-Gut-Brain Axis in Neuropsychiatry. CNS Drugs. 30(11):1019–1041.
  • Shi RR, Wang J, Yan XL, Hu JH, Gao ZP, Jia MX, Yu X. 2011. Effective mechanism of iridoid constituents of Zhizhuxiang (Valeriana jatamans Rhizome) in rats with irritable bowel syndrome. J Beijing Univ Tradit Chin Med. 36:1235–1238.
  • Singh N, Gupta AP, Singh B, Kaul VK. 2006. Quantification of Valerenic acid in Valeriana jatamansi and Valeriana officinalis by HPTLC. Chroma. 63(3-4):209–213.
  • Song H, Yu ZL, Yang MJ, Zhang T, Wang HY. 2018. Analysis of microbial abundance and community composition in esophagus and intestinal tract of wild veined rapa whelk (Rapana venosa) by 16S rRNA gene sequencing. J Gen Appl Microbiol. 64(4):158–166.
  • Subhan F, Karim N, Gilani AH, Sewell RDE. 2010. Terpenoid content of Valeriana wallichii extracts and antidepressant-like response profiles. Phytother Res. 24(5):686–691.
  • Tan YZ. 2019. Chemical constituents from Valeriana jatamansi and their antitumor activities. Chin Tradit Pat Med. 41:572–576.
  • Tang Y, Liu X, Yu B. 2002. Iridoids from the rhizomes and roots of Valeriana jatamansi. J Nat Prod. 65(12):1949–1952.
  • Tao SY. 2017. The therapeutic effect of Valeriana jatamasi component ZXY on IBS model rats and its peripheral mechanism on blood–gut interaction [master’s thesis]. [Beijing: Beijing University of Chinese Medicine].
  • Tikiyani V, Babu K. 2019. Claudins in the brain: unconventional functions in neurons. Traffic. 20(11):807–814.
  • Tobiansky DJ, Kachkovski GV, Enos RT, Schmidt KL, Murphy EA, Soma KK. 2020. Sucrose consumption alters steroid and dopamine signalling in the female rat brain. J Endocrinol. 245(2):231–246.
  • Wang L, Sun Y, Zhao T, Li Y, Zhao X, Zhang L, Wu L, Zhang L, Zhang T, Wei G, et al. 2020. Antidepressant effects and mechanisms of the total iridoids of Valeriana jatamansi on the Brain-Gut Axis. Planta Med. 86(3):172–179.
  • Wang LP, Jianfan F. Hukaili.   2014. Progress in regulation effect of aromatic refreshing traditional Chinese medicine on BBB permeability and its mechanism. J Tradit Chin Med. 39:949–954.
  • Xu KK, Li SH, Zuo CY, Chen CY, Zhang RT, Lan M, Lin Y, Zhang TE, Yan ZY. 2014. Content determination of chlorovaltrate and valjatrate B in total iridoids of Valerianae jatamansi Rhizoma et radix. Chin J Exp Tradit Med Formul. 20(16):64–66.
  • Xu KK, Lin Y, Zhang R, Lan M, Chen C, Li S, Zuo C, Chen C, Zhang T, Yan Z. 2015. Evaluation of safety of iridoids rich fraction from Valeriana jatamansi Jones: acute and sub-chronic toxicity study in mice and rats. J Ethnopharmacol. 172:386–394.
  • Yang Y, Kimura-Ohba S, Thompson JF, Salayandia VM, Cosse M, Raz L, Jalal FY, Rosenberg GA. 2018. Vascular tight junction disruption and angiogenesis in spontaneously hypertensive rat with neuroinflammatory white matter injury. Neurobiol Dis. 114:95–110.
  • Zhang J, Takahashi HK, Liu K, Wake H, Liu R, Maruo T, Date I, Yoshino T, Ohtsuka A, Mori S, et al. 2011. Anti-high mobility group box-1 monoclonal antibody protects the blood–brain barrier from ischemia-induced disruption in rats. Stroke. 42(5):1420–1428.
  • Zhang MZ. 2015. The effect of intestinal microbiota on the permeability of blood–brain barrier in mice. Prog Physiol Sci. 46(2):132–132.
  • Zhu J, Xu K, Zhang X, Cao J, Jia Z, Yang R, Ma C, Chen C, Zhang T, Yan Z. 2016. Studies on the regulation of lipid metabolism and its mechanism of the iridoids rich fraction in Valeriana jatamansi Jones. Biomed Pharmacother. 84:1891–1898.